|
Male Breast Cancer
|
|
Breast Cancer, Male
|
Male Breast Cancer Clinical Trials
- Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002680 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003253 - Active, not recruiting
Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
- Sorafenib in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00096434 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
ClinicalTrials.gov Identifier: NCT00059852 - Active, not recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
Breast Cancer; Male Breast Cancer
- PET Scans in Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00109785 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00002679 - Active, not recruiting
Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00079118 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/neu
ClinicalTrials.gov Identifier: NCT00085020 - Active, not recruiting
stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00080665 - Active, not recruiting
Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Irinotecan and Cetuximab in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00275041 - Active, not recruiting
Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer
- GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00068588 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/neu-Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00077376 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00054470 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00028990 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00132002 - Active, not recruiting
Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
- SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00005822 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer; Male Breast Cancer
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00088998 - Active, not recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00265733 - Active, not recruiting
Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
- Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00024154 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- CP-724,714 in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00055926 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00107510 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Trastuzumab Plus Interleukin-2 in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006228 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
- Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00054275 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
- Lapatinib and Tamoxifen in Treating Patients with Locally Advanced Or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
ClinicalTrials.gov Identifier: NCT00118157 - Recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Radiolabeled SMT-487 in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006370 - Active, not recruiting
Male Breast Cancer; Recurrent Small Cell Lung Cancer; stage IV breast cancer; recurrent breast cancer
- Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00070564 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer
- XRP9881 or Capecitabine in Treating Patients With Recurrent Inoperable or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00107406 - Recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00093808 - Recruiting
recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
ClinicalTrials.gov Identifier: NCT00098605 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; brain metastases; Male Breast Cancer
- Comparison of Two Methods of Genetics Education and Counseling for Breast Cancer
ClinicalTrials.gov Identifier: NCT00019877 - Active, not recruiting
Ovarian Epithelial Cancer; Male Breast Cancer; Breast Cancer
- Decitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00030615 - Active, not recruiting
adult solid tumor; Bladder Cancer; Breast Cancer; Male Breast Cancer; Melanoma
- Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00068757 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00086957 - Recruiting
stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
- Docetaxel With or Without Vaccine Therapy and GM-CSF in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00217750 - Recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
ClinicalTrials.gov Identifier: NCT00070252 - Active, not recruiting
inflammatory breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; unspecified adult solid tumor, protocol specific
- Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00022204 - Active, not recruiting
stage I breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage II breast cancer; Quality of Life; Lymphedema
- Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
ClinicalTrials.gov Identifier: NCT00003135 - Recruiting
Breast Cancer; Cervical Cancer; Endometrial Cancer; Male Breast Cancer; ovarian epithelial cancer; ovarian germ cell tumor
- Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00006225 - Active, not recruiting
Breast Cancer; Leukemia; Lymphoma; Male Breast Cancer; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
- Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00128622 - Recruiting
adult solid tumor; Breast Cancer; Colorectal Cancer; Lung Cancer; Male Breast Cancer; Pancreatic Cancer
- FR901228 in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00098397 - Completed
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00095888 - Completed
recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
- Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00045097 - Completed
Male Breast Cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00054145 - Completed
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Irofulven in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003796 - Completed
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005798 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer; ...
- Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00002616 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; inflammatory breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004156 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
ClinicalTrials.gov Identifier: NCT00039052 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; recurrent non-small cell lung cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; ...
- Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00217659 - Completed
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00107484 - Completed
Breast Cancer; Male Breast Cancer
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
ClinicalTrials.gov Identifier: NCT00002509 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00045188 - Completed
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00004174 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00071942 - Completed
stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
- Chemotherapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00012129 - Completed
stage IIIB breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00039455 - Completed
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00046891 - Active, not recruiting
neurotoxicity; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Nutrition Intervention in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002564 - Active, not recruiting
prevention of breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00044993 - Completed
Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00080626 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00054418 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00017394 - Completed
Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
- Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004172 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
ClinicalTrials.gov Identifier: NCT00024102 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003068 - Active, not recruiting
stage IIIB breast cancer; Drug Toxicity; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
ClinicalTrials.gov Identifier: NCT00033397 - Recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004205 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; breast cancer in situ; recurrent breast cancer; ductal breast carcinoma; ...
- Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
ClinicalTrials.gov Identifier: NCT00002707 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Trastuzumab and Radiation Therapy in Treating Women With Stage III or Stage IV Invasive Primary Cancer of the Breast
ClinicalTrials.gov Identifier: NCT00006109 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
- Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00028704 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
- ICI 182780 in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00002460 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
ClinicalTrials.gov Identifier: NCT00003016 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002581 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075413 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer; stage IIIA breast cancer
- Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
ClinicalTrials.gov Identifier: NCT00070031 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00066378 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
ClinicalTrials.gov Identifier: NCT00015886 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Physical Activity in Preventing Breast Cancer in Women With a History of Breast Cancer or at High Risk for Breast Cancer Who Are Not Physically Active
ClinicalTrials.gov Identifier: NCT00095849 - Active, not recruiting
Breast Cancer
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002579 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Tamoxifen in Treating Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002542 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00088829 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Erlotinib in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00024219 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00008034 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006120 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006032 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Medroxyprogesterone in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
- Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
ClinicalTrials.gov Identifier: NCT00096369 - Active, not recruiting
Breast Cancer; lobular breast carcinoma in situ
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
